Gut Microbiome Is Associated With the Response to Chemoradiotherapy in Patients With Non-small Cell Lung Cancer

被引:11
|
作者
Qiu, Bo [1 ]
Xi, Yu [2 ,3 ]
Liu, FangJie [1 ]
Li, Ying [2 ]
Xie, XinQiang [2 ]
Guo, JinYu [1 ]
Guo, SuPing [1 ]
Wu, YingJia [1 ]
Wu, Lei [2 ]
Liang, TingTing [2 ]
Ding, Yu [2 ]
Zhang, Jumei [2 ]
Wu, QingPing [2 ]
Liu, Hui [1 ]
机构
[1] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Radiat Oncol,Canc Ctr, Guangzhou, Peoples R China
[2] Guangdong Acad Sci, Inst Microbiol, Guangdong Prov Key Lab Microbial Safety & Hlth, State Key Lab Appl Microbiol Southern China, Guangzhou, Peoples R China
[3] South China Univ Technol, Sch Biol & Biol Engn, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
PREDICTIVE FACTORS; RADIOTHERAPY; CHEMORADIATION; BACTERIA; THERAPY;
D O I
10.1016/j.ijrobp.2022.07.032
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To explore the dynamic change of gut microbiota and its predictive role in progression-free survival (PFS) in nonsmall cell lung cancer (NSCLC) after concurrent chemoradiotherapy (CCRT). Methods and Materials: Forty-one patients with NSCLC in 2 phase 2 trials (NCT02573506 and NCT03006575) were analyzed. A total of 102 fecal samples were collected at 3 time points (T0, before CCRT; T1, 2 weeks after the initiation of CCRT; and T2, the end of CCRT). Gut microbiota composition and functionality were analyzed by 16S rRNA gene sequencing and shotgun metagenomics, respectively. Alpha diversity, taxonomic composition, and KEGG functional pathways were compared between patients in the long-PFS group (PFS & GE;11.0 months) and short-PFS group (PFS <11.0 months). A random forest classifier was constructed to identify microbial signature related to PFS. Clinical and microbial factors potentially predictive of PFS were assessed in the univariate and multivariate Cox regression analysis. Results: The abundance of Bacteroidota and Proteobacteria increased, while the abundance of Firmicutes decreased after CCRT. Shannon index (P = .006) and PD index (P = .022) were significantly higher in the long-PFS group than for those in the short-PFS group at T1. The PFS-prediction microbial signature at T1 included unclassified members of the Lanchospiraceae spp., such as NK4A136 and UCG-003 groups, Dorea sp., various strains from within the Eubacterium hallii and E. siraeum groups, and an unclassified member of the Muribaculaceae, which yielded an area under the ROC curve of 0.87. These discriminatory genera mostly belong to phylum Firmicutes/family Clostridia. Multivariate analysis indicated PD index (HR = 8.036, P = .016) and the abundance of Dorea sp. at T1 (HR = 4.186, P = .043) were independent predictors of PFS. The KEGG pathways at T1 overrepresented in the long-PFS group included fatty acid metabolism, fatty acid biosynthesis, and arginine biosynthesis. Those overrepresented in the short-PFS group included lipopolysaccharide biosynthesis, ascorbate and aldarate metabolism, and biosynthesis of vancomycin group antibiotics.Conclusions: Gut microbiota composition and functionality at 2 weeks after the initiation of CCRT were associated with PFS in NSCLC. Further research is needed to confirm these results. & COPY; 2022 Elsevier Inc. All rights reserved.
引用
收藏
页码:407 / 418
页数:12
相关论文
共 50 条
  • [31] Predicting the response to chemotherapy in patients with non-small cell lung cancer
    Wislez, M.
    Antoine, M.
    Lavole, A.
    Gounant, V.
    Milleron, B.
    Cadranel, J.
    REVUE DES MALADIES RESPIRATOIRES, 2007, 24 (08) : S206 - S210
  • [32] Cancer cachexia associated with gut microbiota and clinical outcomes of patients with non-small cell lung cancer amenable to immunotherapy
    Hakozaki, T.
    Nolin-Lapalme, A.
    Kogawa, M.
    Okuma, Y.
    Nakamura, S.
    Tamura, T.
    Hosomi, Y.
    Takeyama, H.
    Richard, C.
    Hosokawa, M.
    Routy, B.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1045 - S1045
  • [33] ASSESSING THE UTILIZATION OF DIABETIC NON-SMALL CELL LUNG CANCER PATIENTS COMPARED TO NON-SMALL CELL LUNG CANCER PATIENTS
    Ruban, C.
    Blanchette, C. M.
    Howden, R.
    Kowalkowski, M.
    Marino, J.
    Saunders, W.
    VALUE IN HEALTH, 2017, 20 (09) : A511 - A511
  • [34] The role of the gut microbiome on the efficacy of immune checkpoint inhibitors in Japanese responder patients with advanced non-small cell lung cancer
    Katayama, Yuki
    Yamada, Tadaaki
    Shimamoto, Takayuki
    Iwasaku, Masahiro
    Kaneko, Yoshiko
    Uchino, Junji
    Takayama, Koichi
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (06) : 847 - +
  • [35] Asthma caused by durvalumab after chemoradiotherapy in two patients with non-small cell lung cancer
    Uemura, Takehiro
    Fukumitsu, Kensuke
    Maeno, Ken
    Fukuda, Satoshi
    Onuki, Tomohiro
    Kanemitsu, Yoshihiro
    Oguri, Tetsuya
    Niimi, Akio
    Hida, Toyoaki
    RESPIROLOGY CASE REPORTS, 2021, 9 (09):
  • [36] Durvalumab After Chemoradiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer
    Mooradian, Meghan J.
    Cai, Ling
    Wang, Alice
    Qiao, Yao
    Chander, Pratibha
    Whitaker, Ryan M.
    JAMA NETWORK OPEN, 2024, 7 (04) : e247542
  • [37] Treatment Efficacy Of Preoperative Chemoradiotherapy For Patients With Locally Advanced Non-small cell Lung Cancer
    Sasaki, T.
    Uehara, S.
    Abe, M.
    Shioyama, Y.
    Nakamura, K.
    Sugio, K.
    Ichinose, Y.
    Hirata, H.
    Honda, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S624 - S625
  • [38] Clinical significance of BIM deletion polymorphism on chemoradiotherapy in patients with non-small cell lung cancer
    Wakabayashi, Yu
    Masuda, Takeshi
    Sakamoto, Shinjiro
    Fujitaka, Kazunori
    Hamada, Hironobu
    Hattori, Noboru
    CANCER SCIENCE, 2021, 112 : 498 - 498
  • [39] DEFINITIVE THORACIC CHEMORADIOTHERAPY IN NON-SMALL CELL LUNG CANCER PATIENTS WITH SOLITARY BRAIN METASTASIS
    Parlak, C.
    Guler, O. C.
    Ozyilkan, O.
    ANNALS OF ONCOLOGY, 2012, 23 : 425 - 425
  • [40] Outcomes of Concurrent Chemoradiotherapy in Elderly Patients with Stage III Non-Small Cell Lung Cancer
    Lee, Seok Ho
    Lee, Seung Heon
    Heo, Ho-Jin
    Sung, Kihoon
    Lee, Kyu Chan
    Jung, Sung Hwan
    Park, Jeong Woong
    Cho, Eun Kyung
    Ahn, Hee Kyung
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S685 - S685